Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
flumatinib (1 trial)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 4)
Trials (1 total)
Trial APIs (1 total)